1. Home
  2. CGEN vs HUHU Comparison

CGEN vs HUHU Comparison

Compare CGEN & HUHU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEN
  • HUHU
  • Stock Information
  • Founded
  • CGEN 1993
  • HUHU 2015
  • Country
  • CGEN Israel
  • HUHU China
  • Employees
  • CGEN N/A
  • HUHU N/A
  • Industry
  • CGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • HUHU
  • Sector
  • CGEN Health Care
  • HUHU
  • Exchange
  • CGEN Nasdaq
  • HUHU NYSE
  • Market Cap
  • CGEN 117.8M
  • HUHU 106.3M
  • IPO Year
  • CGEN 2000
  • HUHU 2024
  • Fundamental
  • Price
  • CGEN $1.47
  • HUHU $4.93
  • Analyst Decision
  • CGEN Strong Buy
  • HUHU
  • Analyst Count
  • CGEN 1
  • HUHU 0
  • Target Price
  • CGEN $4.00
  • HUHU N/A
  • AVG Volume (30 Days)
  • CGEN 216.5K
  • HUHU 19.8K
  • Earning Date
  • CGEN 05-19-2025
  • HUHU 02-22-2025
  • Dividend Yield
  • CGEN N/A
  • HUHU N/A
  • EPS Growth
  • CGEN N/A
  • HUHU N/A
  • EPS
  • CGEN N/A
  • HUHU N/A
  • Revenue
  • CGEN $27,589,000.00
  • HUHU $18,149,244.00
  • Revenue This Year
  • CGEN $11.81
  • HUHU N/A
  • Revenue Next Year
  • CGEN $28.37
  • HUHU N/A
  • P/E Ratio
  • CGEN N/A
  • HUHU N/A
  • Revenue Growth
  • CGEN N/A
  • HUHU 8.47
  • 52 Week Low
  • CGEN $1.13
  • HUHU $2.95
  • 52 Week High
  • CGEN $2.66
  • HUHU $9.89
  • Technical
  • Relative Strength Index (RSI)
  • CGEN 53.98
  • HUHU N/A
  • Support Level
  • CGEN $1.38
  • HUHU N/A
  • Resistance Level
  • CGEN $1.56
  • HUHU N/A
  • Average True Range (ATR)
  • CGEN 0.08
  • HUHU 0.00
  • MACD
  • CGEN 0.02
  • HUHU 0.00
  • Stochastic Oscillator
  • CGEN 68.97
  • HUHU 0.00

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

About HUHU HUHUTECH INTL GROUP INC

HUHUTECH International Group Inc specializes in providing factory facility management and monitoring systems, including high-purity gas, chemicals and liquid system and factory management and control systems for industrial clients, who are mainly semi-conductor manufacturers and electronics manufacturers in China. The products and services are widely used by semi-conductor manufacturers, LED and micro-electronics factories, as well as some pharmaceutical, food and beverage manufacturers.

Share on Social Networks: